Back to Search
Start Over
The Percentage of Anaplastic Lymphoma Kinase-Positive Tumor Cells Has Clinical Implications for Patients with Non-Small Cell Lung Cancer
- Source :
- Genetic Testing and Molecular Biomarkers. 23:589-597
- Publication Year :
- 2019
- Publisher :
- Mary Ann Liebert Inc, 2019.
-
Abstract
- Objectives: Anaplastic lymphoma kinase (ALK) is one of the leading therapeutic targets in patients with non-small cell lung cancer (NSCLC). However, the clinical importance that the percentage of A...
- Subjects :
- Male
Lung Neoplasms
Tumor cells
Cancer Survivors
Risk Factors
Carcinoma, Non-Small-Cell Lung
hemic and lymphatic diseases
medicine
Humans
Anaplastic lymphoma kinase
Anaplastic Lymphoma Kinase
In patient
Lung cancer
In Situ Hybridization, Fluorescence
Genetics (clinical)
medicine.diagnostic_test
business.industry
General Medicine
Middle Aged
Prognosis
medicine.disease
Survival Analysis
respiratory tract diseases
Cancer research
Female
Non small cell
business
Anaplastic Lymphoma Kinase Positive
Fluorescence in situ hybridization
Subjects
Details
- ISSN :
- 19450257 and 19450265
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Genetic Testing and Molecular Biomarkers
- Accession number :
- edsair.doi.dedup.....5b147c7c948f773bce32d5a87ffe9d19